Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Terho Lehtimäki
Pharmacogenetics of Apolipoprotein E Gene During Lipid-Lowering Therapy: Lipid Levels and Prevention of Coronary Heart Disease
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
‹
2
3
4
Related publications
Systematic Review of Lipid Lowering for Primary Prevention of Coronary Heart Disease in Diabetes
BMJ
The Role of Aggressive Lipid Lowering Therapy for Coronary Artery Disease
Juntendo Medical Journal
Apolipoprotein(a) Phenotypes, Lp(a) Concentration and Plasma Lipid Levels in Relation to Coronary Heart Disease in a Chinese Population: Evidence for the Role of the Apo(a) Gene in Coronary Heart Disease.
Journal of Clinical Investigation
Medicine
Lipid Lowering and Plaque Regression. New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Lipid Lowering Therapy and Circulating PCSK9 Concentration
Journal of Atherosclerosis and Thrombosis
Biochemistry
Internal Medicine
Cardiovascular Medicine
Cardiology
Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology
Low-Density Lipoprotein, Non–High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Controversial Issues of Pathogenesis and Lipid-Lowering Therapy of Atherosclerosis
Clinical pharmacology and therapy
The Effects of Lipid-Lowering Therapy on Graft Patency in Coronary Bypass Surgery Patients
Heart Surgery Forum
Surgery
Cardiovascular Medicine
Cardiology